À propos de la propriété intellectuelle Formation en propriété intellectuelle Respect de la propriété intellectuelle Sensibilisation à la propriété intellectuelle La propriété intellectuelle pour… Propriété intellectuelle et… Propriété intellectuelle et… Information relative aux brevets et à la technologie Information en matière de marques Information en matière de dessins et modèles industriels Information en matière d’indications géographiques Information en matière de protection des obtentions végétales (UPOV) Lois, traités et jugements dans le domaine de la propriété intellectuelle Ressources relatives à la propriété intellectuelle Rapports sur la propriété intellectuelle Protection des brevets Protection des marques Protection des dessins et modèles industriels Protection des indications géographiques Protection des obtentions végétales (UPOV) Règlement extrajudiciaire des litiges Solutions opérationnelles à l’intention des offices de propriété intellectuelle Paiement de services de propriété intellectuelle Décisions et négociations Coopération en matière de développement Appui à l’innovation Partenariats public-privé Outils et services en matière d’intelligence artificielle L’Organisation Travailler avec nous Responsabilité Brevets Marques Dessins et modèles industriels Indications géographiques Droit d’auteur Secrets d’affaires Académie de l’OMPI Ateliers et séminaires Application des droits de propriété intellectuelle WIPO ALERT Sensibilisation Journée mondiale de la propriété intellectuelle Magazine de l’OMPI Études de cas et exemples de réussite Actualités dans le domaine de la propriété intellectuelle Prix de l’OMPI Entreprises Universités Peuples autochtones Instances judiciaires Ressources génétiques, savoirs traditionnels et expressions culturelles traditionnelles Économie Égalité des genres Santé mondiale Changement climatique Politique en matière de concurrence Objectifs de développement durable Technologies de pointe Applications mobiles Sport Tourisme PATENTSCOPE Analyse de brevets Classification internationale des brevets Programme ARDI – Recherche pour l’innovation Programme ASPI – Information spécialisée en matière de brevets Base de données mondiale sur les marques Madrid Monitor Base de données Article 6ter Express Classification de Nice Classification de Vienne Base de données mondiale sur les dessins et modèles Bulletin des dessins et modèles internationaux Base de données Hague Express Classification de Locarno Base de données Lisbon Express Base de données mondiale sur les marques relative aux indications géographiques Base de données PLUTO sur les variétés végétales Base de données GENIE Traités administrés par l’OMPI WIPO Lex – lois, traités et jugements en matière de propriété intellectuelle Normes de l’OMPI Statistiques de propriété intellectuelle WIPO Pearl (Terminologie) Publications de l’OMPI Profils nationaux Centre de connaissances de l’OMPI Série de rapports de l’OMPI consacrés aux tendances technologiques Indice mondial de l’innovation Rapport sur la propriété intellectuelle dans le monde PCT – Le système international des brevets ePCT Budapest – Le système international de dépôt des micro-organismes Madrid – Le système international des marques eMadrid Article 6ter (armoiries, drapeaux, emblèmes nationaux) La Haye – Le système international des dessins et modèles industriels eHague Lisbonne – Le système d’enregistrement international des indications géographiques eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Médiation Arbitrage Procédure d’expertise Litiges relatifs aux noms de domaine Accès centralisé aux résultats de la recherche et de l’examen (WIPO CASE) Service d’accès numérique aux documents de priorité (DAS) WIPO Pay Compte courant auprès de l’OMPI Assemblées de l’OMPI Comités permanents Calendrier des réunions WIPO Webcast Documents officiels de l’OMPI Plan d’action de l’OMPI pour le développement Assistance technique Institutions de formation en matière de propriété intellectuelle Mesures d’appui concernant la COVID-19 Stratégies nationales de propriété intellectuelle Assistance en matière d’élaboration des politiques et de formulation de la législation Pôle de coopération Centres d’appui à la technologie et à l’innovation (CATI) Transfert de technologie Programme d’aide aux inventeurs WIPO GREEN Initiative PAT-INFORMED de l’OMPI Consortium pour des livres accessibles L’OMPI pour les créateurs WIPO Translate Speech-to-Text Assistant de classification États membres Observateurs Directeur général Activités par unité administrative Bureaux extérieurs Avis de vacance d’emploi Achats Résultats et budget Rapports financiers Audit et supervision
Arabic English Spanish French Russian Chinese
Lois Traités Jugements Recherche par ressort juridique

WIPO Lex

WIPOLEX003-j

Retour

Court of Justice of the European Union (Fifth Chamber) [2004]: IMS Health GmbH & Co. OHG v NDC Health GmbH & Co. KG, Case No. C-418/01



This is an informal case summary prepared for the purposes of facilitating exchange during the 2023 WIPO IP Judges Forum.

Session 4: Intellectual Property and Competition Issues

Court of Justice of the European Union (Fifth Chamber) [2004]: IMS Health GmbH & Co. OHG v NDC Health GmbH & Co. KG, Case No. C-418/01

Date of judgment: April 29, 2004
Issuing authority: Court of Justice of the European Union
Level of the issuing authority: Final instance
Type of procedure: Judicial (Civin( �br> Subject matter: Copyright; Competition
Plaintiff: IMS Health GmbH & Co. OHG
Defendant: NDC Health GmbH & Co. KG
Keywords: Database, Copyright, Refusal to grant a license, Abuse of dominant position

Basic facts: IMS Health GmbH & Co. OHG (“IMS”) was a German company engaged in tracking sales of pharmaceutical and healthcare products. IMS provided pharmaceutical laboratories with data on regional sales of pharmaceutical products in Germany, formatted according to brick structures consisting of a number of bricks created by taking account of various criteria. IMS not only marketed its brick structures, but also distributed them free of charge to pharmacies and doctors’ surgeries. That practice helped those structures become the industry standard, to which IMS’s clients adapted their information and distribution system.

A former manager of IMS created a new company, “PII”, whose activity also consisted of marketing regional data on pharmaceutical products in Germany formatted on the basis of brick structures. Eventually, on account of reticence expressed by potential clients, who were accustomed to the database distributed by IMS, PII decided to use brick structures very similar to those used by IMS.

PII was later acquired by NDC Health GmbH & Co. KG (“NDC”).

On application by IMS, an interlocutory order prohibiting PII from using the abovementioned structures was granted by the Landgericht Frankfurt am Main (first instance court). After PII’s acquisition by NDC, the same prohibition was issued in respect of the latter. Those orders were both confirmed by the Oberlandesgericht Frankfurt am Main (appellate court), which based its decision on the finding that the brick structure used by IMS was a database within the meaning of Section 4 of the Urheberrechtsgesetz (Act on Copyright and Related Rights) and therefore eligible for copyright protection.

In the main proceedings, IMS pursued a final injunction prohibiting NDC from using the controverted brick structure. The Landgericht Frankfurt am Main took the view that IMS could not exercise its right to obtain an injunction prohibiting all unlawful use of its work if it acted in an abusive manner, within the meaning of article 82 EC, by refusing to grant a license to NDC on reasonable terms. It therefore stayed the proceedings and referred the matter to the Court of Justice of the European Union (CJEU) for a preliminary ruling.

Held: When an undertaking holds a dominant position and owns an intellectual property right in a brick structure indispensable to the presentation of regional sales data on pharmaceutical products in a Member State, its refusal to grant a license to another undertaking that wishes to provide such data in the same Member State constitutes an abuse of a dominant position within the meaning of Article 82 EC where the following conditions are fulfilled:

– the undertaking that requested the license intends to offer, on the market for the supply of the data in question, new products or services not offered by the owner of the intellectual property right and for which there is a potential consumer demand; and

– the refusal is not justified by objective considerations; and

– the refusal is such as to reserve to the owner of the intellectual property right the market or the supply of data on sales of pharmaceutical products in the Member State concerned by eliminating all competition on that market.

Relevant holdings in relation to intellectual property and competition issues:
The CJEU considered whether an undertaking that holds a dominant position in a given market, and owns an intellectual property right to a product indispensable for carrying on business in that market, engaged in abusive conduct by refusing to grant a license to use that product. Referring to the case law, the Court bases its answer on the following grounds:

– The exclusive right of reproduction forms part of the rights of the owner of an IPR, so that refusal to grant a license, even if it is the act of an undertaking holding a dominant position, cannot in itself constitute abuse of a dominant position.

– Nevertheless, exercise of an exclusive right by the owner may, in exceptional circumstances, involve abusive conduct.

– In order for such a scenario to be deemed to exist, it is sufficient, in the case of a refusal by an undertaking which holds a copyright to grant access to a product or service which is indispensable for carrying on a particular business, that three cumulative conditions are met: (i) the refusal prevents the emergence of a new product for which there is potential consumer demand; (ii) it is unjustified; and (iii) it is likely to eliminate all competition on a secondary market.

The circumstances of the case revealed a significant dispute as to the interpretation of the third condition. In this respect, the Court held that: (i) it is sufficient that a potential market or even hypothetical market can be identified, which is the case where the products or services are indispensable in order to carry on a particular business and where there is an actual demand for them on the part of undertakings wishing to carry on the business for which they are indispensable; and (ii) what is decisive is that two distinct stages of production can be identified and that they are interrelated, the upstream product being indispensable for supplying the downstream product.

The Court also clarified the interpretation of the first condition, stating that it is only fulfilled if the undertaking seeking the license does not intend to limit itself to essentially duplicating the goods or services already offered on the secondary market by the intellectual property right holder, but intends to produce new goods or services not offered by the right holder and for which there is a potential consumer demand.

Relevant legislation:
Article 82 of the Treaty establishing the European Community (EC Treaty), now Article 102 of the Treaty on the Functioning of the European Union (TFEU)
Article 4 of the Act on Copyright and Related Rights (Urheberrechtsgesetz)